Academic pharmacist Nataly Martini discusses the medical management of asthma in adults and adolescents, which has evolved to prioritise early anti-inflammatory treatment. She also explains how to improve patient outcomes by proactively identifying poor asthma control and supporting equitable access to education and treatment
FDA issues azithromycin alert
+News
FDA issues azithromycin alert
Wednesday 8 August 2018, 02:56 PM

The US FDA is advising healthcare professionals not to prescribe long-term azithromycin for prophylaxis of bronchiolitis obliterans syndrome to patients who undergo donor stem cell transplants because of increased potential for cancer relapse and death
Medsafe is aware of a US warning that the antibiotic azithromycin can be harmful to blood and lymph node cancer patients who have undergone stem cell
Kia ora and welcome to Pharmacy Today Kaitiaki Rongoā O Te Wā
Not a subscriber? Unlock this article by subscribing here.